Recent Updates
Recently added Catalysts

Hyperbaric Oxygen Therapy

Phase 2

TBI Traumatic Brain Injury | Small molecule | Psychiatry |Summit Therapeutics Inc.|Last Updated: Oct 9, 2025

Success Probability
Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
Premium
Market & Valuation
rNPV $3.2B
Market Size $9.4B
Revenue Basis $1.6B
Competitors 6
Premium
Trial Design
UNCONTROLLEDBiomarker
Total Trials1
Total Enrollment54
FDA Designations
No designations recorded
Clinical Trials (1)
NCT IDTitlePhaseStatusEnrollmentVelocityDesignStartCompletionLast UpdatedSitesCountries
NCT07214415Veterans' Cognitive Function, Mental Health, and Quality of Life After Hyperbaric Oxygen TherapyPHASE2 RECRUITING 54Oct 1, 2025Sep 15, 2026Oct 9, 20251 United States
Unlock Drug Trial Details
Study Endpoints
Primary Endpoints
PTSD Checklist for DSM-5 (PCL-5)
From baseline assessment prior to first HBOT session to immediately after completion of final HBOT session

Self-report questionnaire to assess symptoms of PTSD

NeuroTrax
From baseline assessment prior to first HBOT session to immediately after completion of final HBOT session.

A computerized cognitive test to measure various cognitive functions, including memory, executive functioning, visual-spatial perception, verbal function, attention, information processing speed, and motor skills.

Patient Health Questionnaire-9 (PHQ-9)
From baseline assessment prior to first HBOT session to immediately after completion of final HBOT session

Self-report questionnaire to assess depression severity

Generalized Anxiety Disorder 7-item scale (GAD-7)
From baseline assessment prior to first HBOT session to immediately after completion of final HBOT session

Self-report questionnaire to measure anxiety severity

World Health Organization Quality of Life (WHOQOL-BREF)
From baseline assessment prior to first HBOT session to immediately after completion of final HBOT session

Self-report questionnaire to rate a person's perception of his/her position in their life in the context of physical, psychological, level of independence, social relationships, environment, and spirituality/religion/personal belief domains and facets

Unlock Study Endpoints
Study Design & Arms
AllocationNA
MaskingNONE
ModelSINGLE_GROUP
PurposeTREATMENT
Treatment Arms
ArmTypeDescription
HBOT Intervention GroupEXPERIMENTAL -
Interventions
NameTypeDescription
Hyperbaric Oxygen TherapyDRUGEach HBOT session is scheduled for approximately 95 minutes. The session will begin with a descent of up to 15 minutes (longer if needed for comfort/safety) to a pressure of 2.0 ATA, followed by 30 minutes of breathing 100% oxygen. At the midpoint, there will be a 5-minute air break from oxygen, after which subjects resume breathing 100% oxygen for another 30 minutes. Finally, the session will conclude with an ascent of up to 15 minutes (longer if needed for comfort/safety) back to 1.0 ATA. All sessions are delivered under direct medical supervision with standardized safety protocols. Once approved after medical and behavioral screening, participants complete a battery of cognitive, mental health, and quality of life assessments at baseline (pre-) and after completing the therapy (post-). This arm is distinct from any sham or control interventions because all participants receive the active HBOT treatment.
Unlock Study Design Details
Eligibility Criteria
Age Range18 Years — 75 Years
SexALL
Healthy VolunteersNo
Study Sites1

Inclusion Criteria: 1. At least 18 years of age. 2. Veteran status 3. Clinically diagnosed with a mTBI, PTSD, Anxiety, or Depression disorder by meeting the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, and by a qualified and trained professional. 4. The subject is willing a...

Countries:United States
Unlock Eligibility Criteria
Recent Changes (Last 90 Days)
LOWMay 24, 2026NCT07214415studyFirstPostDate: changed